Upcoming MRK earnings date and every past earnings report, with free AI analysis of each 10-K and 10-Q straight from SEC EDGAR filings.
October 29, 2026
Merck & Co is scheduled to report earnings on this date according to earnings-calendar data from Finnhub and Financial Modeling Prep. Dates can change until the company officially confirms them.
Merck reported a net loss in Q2 FY2026 due to a $5.7 billion acquisition charge, even as revenue grew 5% to $16.6 billion driven by Keytruda and Winrevair.
MRK reported Q1 FY2026 revenue of $16.3B (+4.9% YoY), but swung to a net loss of -$4.24B driven by a massive $12.6B R&D expense surge (+247.7% YoY), likely…
Merck (MRK) delivered modest revenue growth of 1.3% to $65.0B in FY2025, with net income rising 6.6% to $18.3B and EPS up 8.0% to $7.28, though operating cash…
Merck & Co (MRK) is scheduled to report earnings on October 29, 2026, according to Finnhub's earnings calendar. Dates can change until the company officially confirms them.
Merck & Co's most recent earnings report was its Q2 FY2026 10-Q, filed with the SEC on August 7, 2026.
EarningsLens publishes free AI analysis of every MRK 10-K and 10-Q filing. The latest covers Q2 FY2026 — open it from the report history on this page.
Like all U.S.-listed public companies, Merck & Co reports four times a year: three quarterly 10-Q filings and one annual 10-K filing with the SEC.